Roivant Sciences' (ROIV) Dermavant Announces FDA Approval of VTAMA Cream
Go back to Roivant Sciences' (ROIV) Dermavant Announces FDA Approval of VTAMA Cream| DexCom, Inc. (NASDAQ: DXCM) | Delayed: 83.45 +8.91 (11.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $74.54 | 52 Week High | $96.38 | |||
| Open | $79.88 | 52 Week Low | $47.92 | |||
| Day High | $84.70 | P/E | N/A | |||
| Day Low | $79.50 | EPS | $-0.42 | |||
| Volume | 11,981,833 | |||||
| (NASDAQ: ROIV) | Delayed: 33.91 -0.61 (1.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $34.52 | 52 Week High | $ | |||
| Open | $34.28 | 52 Week Low | $ | |||
| Day High | $34.50 | P/E | N/A | |||
| Day Low | $33.54 | EPS | $ | |||
| Volume | 5,397,094 | |||||
